| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $318K | +34.4% | +36.3% |
| SG&A Expense | $699K | -4.2% | -20.7% |
| Operating Income | -$2.4M | -51.9% | -22.2% |
| Pre-tax Income | -$2.4M | -51.8% | -22.1% |
| Income Tax | $0 | — | — |
| Net Income | -$2.4M | -51.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | +155.4% | -27.7% |
| Accounts Receivable | $627 | -23.4% | +114.7% |
| Current Assets | $2.8M | +142.2% | -26.1% |
| Total Assets | $4.9M | +41.6% | -27.3% |
| Current Liabilities | $644K | +21.9% | +31.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | — |
| Investing Cash Flow | -$534K | — | — |
| Financing Cash Flow | $4.9M | — | — |
| -22.1% |
| EPS (Basic) | -$1.59 | +46.1% | -218.0% |
| EPS (Diluted) | -$1.59 | +46.1% | -218.0% |
| $669K |
| +18.7% |
| +20.6% |
| Stockholders' Equity | $4.2M | +46.0% | -31.7% |